Telomerase related molecular subtype and risk model reveal immune activity and evaluate prognosis and immunotherapy response in prostate cancer.

Saved in:
Bibliographic Details
Title: Telomerase related molecular subtype and risk model reveal immune activity and evaluate prognosis and immunotherapy response in prostate cancer.
Authors: Liu, Dongze1 (AUTHOR), Qin, Zheng2 (AUTHOR), Yi, Bocun1 (AUTHOR), Xie, Hongbo1 (AUTHOR), Liang, Yunan1 (AUTHOR), Zhu, Liang1 (AUTHOR), Yang, Kuo1 (AUTHOR), Xu, Yong1 (AUTHOR) xymnwk@163.com, Zhang, Hongtuan1 (AUTHOR) zhtlml@tmu.edu.cn
Source: Cancer Cell International. 8/17/2024, Vol. 24 Issue 1, p1-25. 25p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:14752867
DOI:10.1186/s12935-024-03477-0